Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ALEXIS HOPE JACKMAN

Allopathic & Osteopathic Physicians Otolaryngology

NPI
1245247311
CMS profile
853900
Location
PURCHASE, NY

General Payments · PY2018–2024

$4,213.00

  • Reported across 204 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$904.70

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $904.70 36

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $320.92 18
PY2019 $481.34 27
PY2020 $537.67 29
PY2021 $632.05 35
PY2022 $488.40 22
PY2023 $847.92 37
PY2024 $904.70 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
CSL Behring $25.84 01/11/2024 Food and Beverage Undisputed 01/23/2026 1134649243 CMS
CSL Behring $22.17 10/29/2024 Food and Beverage Undisputed 01/23/2026 1134649417 CMS
Genentech USA, Inc. $32.76 04/09/2024 Food and Beverage Undisputed 01/23/2026 1132974009 CMS
Genentech USA, Inc. $26.66 05/23/2024 Food and Beverage Undisputed 01/23/2026 1132974011 CMS
Genentech USA, Inc. $29.23 06/26/2024 Food and Beverage Undisputed 01/23/2026 1132974013 CMS
GENZYME CORPORATION $32.48 01/16/2024 Food and Beverage Undisputed 01/23/2026 1139692724 CMS
GENZYME CORPORATION $23.77 02/12/2024 Food and Beverage Undisputed 01/23/2026 1139692726 CMS
GENZYME CORPORATION $24.59 04/23/2024 Food and Beverage Undisputed 01/23/2026 1139692752 CMS
GENZYME CORPORATION $34.41 05/16/2024 Food and Beverage Undisputed 01/23/2026 1139692762 CMS
GENZYME CORPORATION $18.82 06/04/2024 Food and Beverage Undisputed 01/23/2026 1139692766 CMS
GENZYME CORPORATION $24.89 07/30/2024 Food and Beverage Undisputed 01/23/2026 1139692800 CMS
GENZYME CORPORATION $26.40 09/05/2024 Food and Beverage Undisputed 01/23/2026 1139692830 CMS
GENZYME CORPORATION $25.00 10/08/2024 Food and Beverage Undisputed 01/23/2026 1139692840 CMS
GENZYME CORPORATION $33.01 12/03/2024 Food and Beverage Undisputed 01/23/2026 1139692854 CMS
GlaxoSmithKline, LLC. $22.32 02/29/2024 Food and Beverage Undisputed 01/23/2026 1116494992 CMS
GlaxoSmithKline, LLC. $30.72 05/06/2024 Food and Beverage Undisputed 01/23/2026 1116542746 CMS
Grifols USA, LLC $21.43 02/08/2024 Food and Beverage Undisputed 01/23/2026 1124754286 CMS
Grifols USA, LLC $19.08 04/29/2024 Food and Beverage Undisputed 01/23/2026 1124754284 CMS
Hikma Pharmaceuticals USA $50.50 05/20/2024 Food and Beverage Undisputed 01/23/2026 1127505518 CMS
kaleo, Inc. $19.30 06/13/2024 Food and Beverage Undisputed 01/23/2026 1126622387 CMS
Neurent Medical Limited $30.88 09/24/2024 Food and Beverage Undisputed 01/23/2026 1098841563 CMS
Novartis Pharmaceuticals Corporation $24.18 01/23/2024 Food and Beverage Undisputed 01/23/2026 1087073882 CMS
Novartis Pharmaceuticals Corporation $24.37 02/26/2024 Food and Beverage Undisputed 01/23/2026 1087073884 CMS
Novartis Pharmaceuticals Corporation $24.12 03/26/2024 Food and Beverage Undisputed 01/23/2026 1087073886 CMS
Novartis Pharmaceuticals Corporation $24.83 07/23/2024 Food and Beverage Undisputed 01/23/2026 1087073888 CMS
Novartis Pharmaceuticals Corporation $27.78 08/15/2024 Food and Beverage Undisputed 01/23/2026 1087073890 CMS
Novartis Pharmaceuticals Corporation $24.51 09/12/2024 Food and Beverage Undisputed 01/23/2026 1087073894 CMS
Novartis Pharmaceuticals Corporation $24.93 10/15/2024 Food and Beverage Undisputed 01/23/2026 1087073896 CMS
Novartis Pharmaceuticals Corporation $21.68 11/12/2024 Food and Beverage Undisputed 01/23/2026 1087073898 CMS
Optinose US, Inc. $28.81 04/03/2024 Food and Beverage Undisputed 01/23/2026 1142188190 CMS
Optinose US, Inc. $18.55 12/04/2024 Food and Beverage Undisputed 01/23/2026 1142188204 CMS
Regeneron Healthcare Solutions, Inc. $14.31 01/18/2024 Food and Beverage Undisputed 01/23/2026 1114075528 CMS
Regeneron Healthcare Solutions, Inc. $17.43 02/20/2024 Food and Beverage Undisputed 01/23/2026 1114075530 CMS
Regeneron Healthcare Solutions, Inc. $18.45 04/02/2024 Food and Beverage Undisputed 01/23/2026 1114075532 CMS
Regeneron Healthcare Solutions, Inc. $15.69 07/11/2024 Food and Beverage Undisputed 01/23/2026 1114075534 CMS
Takeda Pharmaceuticals U.S.A., Inc. $20.80 03/07/2024 Food and Beverage Undisputed 01/23/2026 1137585262 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.